Literature DB >> 11322953

Molecular characterization of human UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, a novel nucleotide sugar transporter with dual substrate specificity.

M Muraoka1, M Kawakita, N Ishida.   

Abstract

A novel human nucleotide sugar transporter (NST) which transports both UDP-glucuronic acid (UDP-GlcA) and UDP-N-acetylgalactosamine (UDP-GalNAc) has been identified, cloned and characterized. The strategy for the identification of the novel NST involved a search of the expressed sequence tags database for genes related to the human UDP-galactose transporter-related isozyme 1, followed by heterologous expression of a candidate gene (hUGTrel7) in Saccharomyces cerevisiae and biochemical analyses. Significantly more UDP-GlcA and UDP-GalNAc were translocated from the reaction medium into the lumen of microsomes prepared from the hUGTrel7-expressing yeast cells than into the control microsomes from cells not expressing hUGTrel7. The possibility that this transporter participates in glucuronidation and/or chondroitin sulfate biosynthesis is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322953     DOI: 10.1016/s0014-5793(01)02358-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  37 in total

1.  Identification of a retroviral receptor used by an envelope protein derived by peptide library screening.

Authors:  Anindita Sarangi; Keith Bupp; Monica J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-20       Impact factor: 11.205

2.  A missense mutation in the bovine SLC35A3 gene, encoding a UDP-N-acetylglucosamine transporter, causes complex vertebral malformation.

Authors:  Bo Thomsen; Per Horn; Frank Panitz; Emøke Bendixen; Anette H Petersen; Lars-Erik Holm; Vivi H Nielsen; Jørgen S Agerholm; Jens Arnbjerg; Christian Bendixen
Journal:  Genome Res       Date:  2005-12-12       Impact factor: 9.043

3.  A second locus for Schneckenbecken dysplasia identified by a mutation in the gene encoding inositol polyphosphate phosphatase-like 1 (INPPL1).

Authors:  Hane Lee; Lisette Nevarez; Ralph S Lachman; William R Wilcox; Deborah Krakow; Daniel H Cohn
Journal:  Am J Med Genet A       Date:  2015-05-22       Impact factor: 2.802

4.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

5.  Molecular and functional characterization of microsomal UDP-glucuronic acid uptake by members of the nucleotide sugar transporter (NST) family.

Authors:  Tsutomu Kobayashi; Judith E Sleeman; Michael W H Coughtrie; Brian Burchell
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

6.  Biosynthesis of GlcNAc-rich N- and O-glycans in the Golgi apparatus does not require the nucleotide sugar transporter SLC35A3.

Authors:  Bozena Szulc; Paulina Sosicka; Dorota Maszczak-Seneczko; Edyta Skurska; Auhen Shauchuk; Teresa Olczak; Hudson H Freeze; Mariusz Olczak
Journal:  J Biol Chem       Date:  2020-09-16       Impact factor: 5.157

7.  The Drosophila neurally altered carbohydrate mutant has a defective Golgi GDP-fucose transporter.

Authors:  Christoph Geisler; Varshika Kotu; Mary Sharrow; Dubravko Rendić; Gerald Pöltl; Michael Tiemeyer; Iain B H Wilson; Donald L Jarvis
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

Review 8.  Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35).

Authors:  Nobuhiro Ishida; Masao Kawakita
Journal:  Pflugers Arch       Date:  2003-05-21       Impact factor: 3.657

9.  UDP-N-acetylglucosamine transporter (SLC35A3) regulates biosynthesis of highly branched N-glycans and keratan sulfate.

Authors:  Dorota Maszczak-Seneczko; Paulina Sosicka; Teresa Olczak; Piotr Jakimowicz; Michał Majkowski; Mariusz Olczak
Journal:  J Biol Chem       Date:  2013-06-13       Impact factor: 5.157

10.  Identification of loss-of-function mutations of SLC35D1 in patients with Schneckenbecken dysplasia, but not with other severe spondylodysplastic dysplasias group diseases.

Authors:  T Furuichi; H Kayserili; S Hiraoka; G Nishimura; H Ohashi; Y Alanay; J C Lerena; A D Aslanger; H Koseki; D H Cohn; A Superti-Furga; S Unger; S Ikegawa
Journal:  J Med Genet       Date:  2009-06-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.